Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 20/20 | 0.47 |
| ▸ | DDB1 | Q16531 | 15/20 | 0.47 |
| ▸ | TNF | P01375 | 3/20 | 0.47 |
| ▸ | IL1B | P01584 | 3/20 | 0.47 |
| ▸ | IKZF3 | Q9UKT9 | 3/20 | 0.47 |
| ▸ | IKZF1 | Q13422 | 2/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2148301 | 0.79 | CRBN (0.47) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL21843690 | 0.78 | CRBN (0.49) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL31243223 | 0.78 | CRBN (0.47) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL2010576 | 0.76 | CRBN (0.48) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL24440131 | 0.73 | CRBN (0.55) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL30751193 | 0.68 | DDB1 (0.46) | CRBNDDB1IKZF3 | |
| SCHEMBL10192652 | 0.68 | CRBN (0.53) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL10192664 | 0.68 | CRBN (0.53) | CRBNDDB1TNFIL1BIKZF3 | |
| SCHEMBL30270626 | 0.67 | CRBN (0.37) | CRBNDDB1 | |
| SCHEMBL6180923 | 0.67 | CRBN (0.46) | CRBNDDB1IKZF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081561-A2 | METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF SPIROCHETE AND OTHER OBLIGATE INTRACELLULAR BACTERIAL DISEASES | CELGENE CORPORATION (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-1933818-A1 | METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LOW PLASMA LEPTIN LEVELS | CELGENE CORPORATION (US) | 2008-06-25 | — | — | EP | disclosed |
| EP-1924250-A2 | COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS AND THE USE THEREOF FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS | CELGENE CORPORATION (US) | 2008-05-28 | — | — | EP | disclosed |
| WO-2008057196-A2 | METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF SPIROCHETE AND OTHER OBLIGATE INTRACELLULAR BACTERIAL DISEASES | CELGENE CORPORATION (US) | 2008-05-15 | — | — | WO | disclosed |
| WO-2006060507-A9 | COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS AND THE USE THEREOF FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS | CELGENE CORP (US) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007033112-A1 | METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LOW PLASMA LEPTIN LEVELS | CELGENE CORPORATION (US) | 2007-03-22 | — | — | WO | disclosed |
| WO-2006060507-A2 | COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS AND THE USE THEREOF FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS | CELGENE CORPORATION (US) | 2006-06-08 | — | — | WO | disclosed |